Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $113.31 million. The enterprise value is $67.28 million.

Market Cap	113.31M
Enterprise Value	67.28M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Immunic has 89.93 million shares outstanding. The number of shares has increased by 39.29% in one year.

Shares Outstanding	89.93M
Shares Change (YoY)	+39.29%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	7.72%
Owned by Institutions (%)	58.08%
Float	49.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.92
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.02.

Current Ratio	2.12
Quick Ratio	n/a
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -157.40% and return on invested capital (ROIC) is -335.55%.

Return on Equity (ROE)	-157.40%
Return on Assets (ROA)	-117.40%
Return on Capital (ROIC)	-335.55%
Revenue Per Employee	n/a
Profits Per Employee	-$1.22M
Employee Count	77
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.23% in the last 52 weeks. The beta is 1.95, so Immunic's price volatility has been higher than the market average.

Beta (1Y)	1.95
52-Week Price Change	-19.23%
50-Day Moving Average	1.33
200-Day Moving Average	1.43
Relative Strength Index (RSI)	47.37
Average Volume (30 Days)	590,953

Short Selling Information

The latest short interest is 2.88 million, so 3.20% of the outstanding shares have been sold short.

Short Interest	2.88M
Short Previous Month	3.03M
Short % of Shares Out	3.20%
Short % of Float	5.82%
Short Ratio (days to cover)	7.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-99.22M
Pretax Income	-93.61M
Net Income	-93.61M
EBITDA	-93.50M
EBIT	-93.61M
Earnings Per Share (EPS)	-$2.11

Full Income Statement

Balance Sheet

The company has $46.67 million in cash and $639,000 in debt, giving a net cash position of $46.04 million or $0.51 per share.

Cash & Cash Equivalents	46.67M
Total Debt	639,000
Net Cash	46.04M
Net Cash Per Share	$0.51
Equity / Book Value	28.93M
Book Value Per Share	0.32
Working Capital	27.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$70.83 million and capital expenditures -$334,000, giving a free cash flow of -$71.16 million.

Operating Cash Flow	-70.83M
Capital Expenditures	-334,000
Free Cash Flow	-71.16M
FCF Per Share	-$1.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.29%
Shareholder Yield	-39.29%
Earnings Yield	-82.62%
FCF Yield	-62.80%

Analyst Forecast

The average price target for Immunic is $8.50, which is 574.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	574.60%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 15, 2019. It was a reverse split with a ratio of 1:40.

Last Split Date	Apr 15, 2019
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	2